ALIGN: A Non-randomised Study Delivering Injectable Lenacapavir for HIV Prevention Within a Pre-exposure Prophylaxis (PrEP) Choice Context in Cape Town, South Africa.

Name: ALIGN: A Non-randomised Study Delivering Injectable Lenacapavir for HIV Prevention Within a Pre-exposure Prophylaxis (PrEP) Choice Context in Cape Town, South Africa.
Published: 2026
License: Public Domain

Desmond Tutu HIV Foundation · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

hiv

hiv, lenacapavir, pre-exposure prophylaxis, prep choice, cabotegravir, observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

ALIGN: A Non-randomised Study Delivering Injectable Lenacapavir for HIV Prevention Within a Pre-exposure Prophylaxis (PrEP) Choice Context in Cape Town, South Africa.

Related documents